Yaqi Zhao
-
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4
-
- Chronic Myeloid Leukemia Treatments 3
-
- Genomics and Phylogenetic Studies 4
- RNA modifications and cancer 3
-
- Acute Lymphoblastic Leukemia research 5
-
- Lepidoptera: Biology and Taxonomy 4
-
- Ferroptosis and cancer prognosis 3
- Cited by
- OncologyCancer ResearchHematology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yaqi Zhao
31 papers receiving 638 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 190
- Cancer Research 97
- Hematology 50
- Immunology 94
- Molecular Biology 302
Countries citing papers authored by Yaqi Zhao
This map shows the geographic impact of Yaqi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqi Zhao more than expected).
Fields of papers citing papers by Yaqi Zhao
This network shows the impact of papers produced by Yaqi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqi Zhao. The network helps show where Yaqi Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yaqi Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 30 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 26 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 3 | |
| 12 | 2020 | 77 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 32 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 15 | |
| 18 | 2017 | 13 | |
| 19 | 2016 | 5 | |
| 20 | 2013 | 21 |
About Yaqi Zhao
Yaqi Zhao is a scholar working on Oncology, Toxicology and Genetics, having authored 34 papers that have together received 646 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Genomics and Phylogenetic Studies (4 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lepidoptera: Biology and Taxonomy (4 papers), Ferroptosis and cancer prognosis (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (190 citations), Cancer Research (97 citations) and Hematology (50 citations). Yaqi Zhao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jie Wu, Huibo Zhang, Bin Xu, Lan Li, Haohan Zhang, Raymond E. Boissy, W. A. Gahl, Tianyu Lei, Zheming Liu and Haoli Ma. Their work appears in journals such as Blood, Nature Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.